Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-08-22
2006-08-22
Chunduru, Suryaprabha (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S024330, C530S350000
Reexamination Certificate
active
07094532
ABSTRACT:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human norepinephrine (NE) transporter variants, as well as in diagnostic and therapeutic applications, relating to a human NE transporter polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human NE transporter with regard to the human NE transporter polymorphism, for example, in the context of diagnosing and treating NE transport impairments, and disorders associated with NE transport impairments, such as orthostatic intolerance.
REFERENCES:
patent: 5580775 (1996-12-01), Fremeau, Jr. et al.
patent: 5763183 (1998-06-01), Pesonen et al.
patent: 6248526 (2001-06-01), Weimer
patent: WO 92/17568 (1992-10-01), None
Jonsson et al. Polymorphisms in the dopamine, serotinin and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Pscychiatry Res., vol. 79, pp. 1-9, 1998.
Flattem et al.Identification of a coding mutation in the norepinephrine transporter gene which predisposes a family to orthosattic intolerance. Am. J Human Genetics, vol. 65, No. 4, p. A43, 1999.
Jacob et al. Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation, vol.. 99, No. 13, pp. 1706-1712, 1999.
Jonsson et al. Polymorphisms in the dopamine, serotinin and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Pscychiatry Res., vol. 79, pp. 1-9, 1998.
Jacob et al. Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation, vol.. 99, No. 13, pp. 1706-1712, 1999.
Stober et al. Systemic search for variation in the human norepinephrine transporter gene: Indentification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet., vol. 67, pp. 523-553 1996.
Flattem et al., “Identification of a Coding Mutation in the Norepinephrine Transporter Gene WHich Predisposes a Family to Orthostatic Intolerance,” Am. J. Human Genet., vol. 65 (No. 4), p. A43, (1999).
Shannon, “Functional Polymorphism of the Norepinephrine Transporter (NET) Presenting as Mitral Valve Prolapse and Orthostatic Intolerance,” Circulation, vol. 110 (No. 18), p. I.195, (Nov. 2, 1999).
Owen et al., “Norepinephrine Transporter Gene Polymorphism is not Associated with Susceptibility to Major Depression,” Psychiatry Research, vol. 87 (No. 1), p. 1-5, (1999).
Pacholczyk et al., “Expression Cloning of a Cocaine and Antidepressant-Sensitive Human Noradrenaline Transporter,” Bio Nature, p. 350-353, (Mar. 28, 1991).
Porzgen et al., “Molecular Cloning and Organization of the Coding region of the Human Norepinephrine Transporter Gene,” Biochem. Biophys. Res. Commun., vol. 215 (No. 3), p. 1145-1150, (Oct. 24, 1995).
Wang et al., “Genetic Approaches to Studying Norepinephrine Function: Knockout of the Mouse Norepinephrine Transporter,” Gene Biol. Psychiatry, p. 1124-1130, (1999).
Anonymous, “Gene Characterization Kits,” In: Stratagene Catalog, p. 39, (1988).
PCT International Search Report for PCT International Application No. PCT/US00/35491.
Jordan et al., “Contrasting Actions of Pressor Agents in Severe Autonomic Failure,” Am. J. Med., vol. 105 (No. 2), p. 116-124, (1998), (Abstract only).
Choy et al., “Abnormalities of the QT Intercal in Primary Disorder of Autonomic Failure,” Am. Heart J., vol. 136 (No. 4), p. 664-671, (1998). (Abstract only).
Jordan et al., “Contrasting Effects of Vasodilators on Blood Pressure and Sodium Balance in the Hypertension of Autonomic Failure,” J. Am. Soc. Nephrol., vol. 10 (No. 1), p. 35-42, (1999). (Abstract only).
Jacob et al., “Effects of Standing on Cerebrovascular Resistance in patients with Idiopathic Orthostatic Intolerance,” Am. J. Med., vol. 106 (No. 1), p. 59-64, (1999). (Abstract only).
Gilman et al., “Consensus Statement on the Diagnosis of Multiple System Atrophy,” J. Neurol. Sci., vol. 163 (No. 1), p. 94-98, (Feb. 1, 1999). (Abstract only).
Shannon et al., “Acute Effect of Ephedrine on 24-h Energy Balance,” Clin. Sci. (Colch), vol. 96 (No. 5), p. 483-491, (1999). (Abstract only).
Jacob et al., “Abnormal norepinephrine Clearance and Adrenergic Receptor Seneiticity in Idiopathic Orthostatic Intolerance,” Circulation, vol. 99 (No. 13), p. 1706-1712, (Apr. 6, 1999), (Abstract only).
Robertson et al., “Neurally Mediated Syncope: Pthophysiology and IMplications for Treatment,” Am. J. Med. Sci., vol. 317 (No. 2), p. 102-109, (1999). (Abstract only).
Austin et al., “Multiple System Atrophy: Clinical Presentation and Diagnosis,” Tenn. Med., vol. 92 (No. 2), p. 55-57, (1999). (Abstract only).
Furlan et al., “Chronic Orthostatic Intolerance: a Disorder with Doscordant Cardiac and Vascular Sympathetic Control,” Circulation, vol. 98 (No. 20), p. 2154-2159, (Nov. 17, 1998). (Abstract only).
Robertson, “Distribution and Observed Associations of Orthostatic Blood Pressure Changes in Elderly General Medicine Outpatients,” Am. J. Med. Si., vol. 315 (No. 5), p. 287-295, (1998). (Abstract only).
Caswell, “Orthostatic Intolerance,” NASA West Virginia Space Grant Consortium, (1997).
“Chronic Orthostatic Intolerance (COI) Nerve Abnormality,” Causes Disabling Rapid Heart Rate, Dizziness, Dallas, Texas, (Nov. 17, 1998).
National Dysautonomia Research Foundation, “Orthostatic Intolerance Syndromes,” (1997).
Stöber et al., Systematic Search for Variation in the Human Norepinephrine Transporter Gene: Identification of Five Naturally Occurring Missense Mutations and Study of Association with Major Psychiatric Disorders,Am. J. of Medical Genetics(Neuropsychiatic Genetics) 67:523-532 (1996).
Blakely Randy D.
Robertson David
Chunduru Suryaprabha
Jenkins Wilson Taylor & Hunt, P.A.
Vanderbilt University
LandOfFree
Genetic mutation underlying orthostatic intolerance and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic mutation underlying orthostatic intolerance and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic mutation underlying orthostatic intolerance and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3631582